56 results
8-K
EX-99.1
STSS
Sharps Technology Inc
13 Jun 24
Sharps Technology Receives $30 Million Purchase Order for Prefillable Copolymer Syringes to be Manufactured at SC Facility
8:30am
products using advanced manufacturing techniques creates additional advantages in the areas of quality, performance, and safety when compared to similar … Technology is an innovative medical device and pharmaceutical packaging company offering patented, best-in-class smart-safety syringe products
8-K
EX-99.1
STSS
Sharps Technology Inc
5 Jun 24
Sharps Technology Secures SC Asset Purchase Exclusivity with $1 Million Escrow Deposit
8:45am
is an innovative medical device and pharmaceutical packaging company offering patented, best-in-class smart-safety syringe products to the healthcare industry … safety features. Sharps also offers products that are designed with specialized copolymer technology to support the prefillable syringe market segment
253G3
STSS
Sharps Technology Inc
4 Jun 24
Offering circular supplement
5:03pm
.
Company Overview
Sharps Technology, Inc. is a medical device company that has designed and patented various safety syringes which we are seeking … to commercialize and other syringe products currently marketable.
Our safety syringes products, which we refer to as the Sharps Provensa™ and Securgard™
8-K
EX-99.1
STSS
Sharps Technology Inc
31 May 24
Regulation FD Disclosure
8:35am
patented, best-in-class smart-safety syringe products to the healthcare industry. The Company’s product lines focus on providing ultra-low waste … capabilities, that incorporate syringe technologies that use both passive and active safety features. Sharps also offers products that are designed
8-K
EX-99.1
STSS
Sharps Technology Inc
28 May 24
Regulation FD Disclosure
1:37pm
and SoloGard syringe lines, are designed to address the specific safety and performance concerns highlighted by the FDA. Our in-demand syringes … feature low waste and ultra-low waste technologies, active safety mechanisms, and WHO-accredited re-use prevention measures, protecting both healthcare
8-K
EX-10.2
ar3m5z krp
24 May 24
Entry into a Material Definitive Agreement
4:15pm
8-K
22eqdvl
24 May 24
Entry into a Material Definitive Agreement
4:15pm
8-K
EX-10.1
1p37bs nqbroggsc
24 May 24
Entry into a Material Definitive Agreement
4:15pm
8-K
EX-10.1
j81cp7cz
8 Mar 24
Entry into a Material Definitive Agreement
4:15pm
8-K
EX-99.1
wits5
7 Mar 24
Regulation FD Disclosure
10:22am
8-K
EX-99.1
g6t37
18 Jan 24
Sharps Technology Signs LOI with Roncadelle Operations Intended to Open Worldwide Sales and Distribution Opportunities for Safe Drug Delivery Systems
9:12am
8-K
EX-99.2
vcdgxa1xzeyoj
3 Oct 23
Sharps Technology Announces $5.6 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules
4:16pm
8-K
EX-99.1
wil0u tzxdb2d
3 Oct 23
Sharps Technology Announces $5.6 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules
4:16pm
424B5
q32kv
29 Sep 23
Prospectus supplement for primary offering
8:00am
8-K
EX-99.1
89fg588k545f sraol
28 Sep 23
Regulation FD Disclosure
11:27am
8-K
EX-10.1
day9nio9
26 Sep 23
Signed term sheet providing for up to $75 Million in debt financing to be used for the acquisition
8:45am